文献速递消化系统肿瘤

中国人群基于多轮次粪便免疫化学试验的结直肠癌筛查参与率与结直肠肿瘤检出情况

[Participation rate and detection of colorectal neoplasms based on multi-round fecal immunochemical testing for colorectal cancer screening in the Chinese population].
PubMed 文献 · Zhonghua Zhong Liu Za Zhi · 2023-01-01

基于2018年5月至2021年5月中国6个中心的人群结直肠癌筛查项目,纳入7 793例50~74岁受试者,连续开展3轮次年度粪便免疫化学试验(FIT)筛查。第1、2、3轮FIT参与率分别为94.0%、86.8%和91.3%,FIT阳性者结肠镜依从率均超过70%,进展期肿瘤检出率逐轮下降而阳性预测值逐轮升高。

要点

  • 3轮FIT参与率分别为94.0%、86.8%和91.3%,99.3%受试者至少参加1轮,66.3%参加全部3轮。
  • FIT阳性者结肠镜依从率3轮均超70%,分别为76.3%、75.7%和71.7%。
  • 进展期肿瘤检出率逐轮下降(1.15%、0.57%、0.58%),阳性预测值逐轮升高(11.02%、15.50%、16.05%)。

核心结论

  • 每年1次的重复FIT筛查在中国人群中具有较好的接受度以及较高的病变检出率。
  • 作者认为,为优化和提升人群结直肠癌筛查效果,应在保证人群筛查参与率的条件下推行多轮次重复FIT筛检。

研究设计与样本

  • 基于2018年5月至2021年5月在中国6个中心开展的一项人群结直肠癌筛查研究。
  • 共纳入7 793例50~74岁符合研究条件的受试者,提供免费FIT检测,FIT初筛阳性者提供结肠镜检查。
  • 基线时所有受试者均受邀接受FIT筛查,后续轮次仅邀请FIT阳性但未接受结肠镜检查者或FIT阴性者进行重复FIT筛查。
  • FIT阳性者推荐接受结肠镜和病理检查(如结肠镜下有异常发现)。
  • 共计开展3轮次每年1次的FIT筛查,主要研究结局为FIT参与率、FIT阳性者结肠镜检查参与率及结直肠肿瘤检出率。

主要发现

  • 7 793例受试者中男3 310人(42.5%),年龄为(60.50±6.49)岁。
  • 第1轮、第2轮和第3轮FIT筛查参与率分别为94.0%(7 327/7 793)、86.8%(6 048/6 968)和91.3%(6 113/6 693)。
  • 99.3%(7 742/7 793)的参与者参加了至少1轮筛查,66.3%(5 163/7 793)参加了全部3轮筛查。
  • 第1轮FIT阳性率(14.6%,1 071/7 327)高于第2轮(5.6%,341/6 048)和第3轮(5.5%,339/6 113)(均P<0.001)。
  • FIT阳性受试者结肠镜检查依从率3轮分别为76.3%(817/1 071)、75.7%(258/341)和71.7%(243/339)。

关键数值与推荐

  • FIT筛查参与率:第1轮94.0%(7 327/7 793)、第2轮86.8%(6 048/6 968)、第3轮91.3%(6 113/6 693)。
  • FIT阳性者结肠镜检查依从率:第1轮76.3%(817/1 071)、第2轮75.7%(258/341)、第3轮71.7%(243/339)。
  • FIT阳性率:第1轮14.6%(1 071/7 327)、第2轮5.6%(341/6 048)、第3轮5.5%(339/6 113),第1轮高于第2、3轮(均P<0.001)。
  • 进展期肿瘤检出率:第1轮1.15%(90/7 793)、第2轮0.57%(40/6 968)、第3轮0.58%(39/6 693)。
  • 进展期肿瘤阳性预测值:第1轮11.02%、第2轮15.50%、第3轮16.05%。

临床怎么用

  • 作者认为,应在保证人群筛查参与率的条件下推行多轮次重复FIT筛检,以优化和提升人群结直肠癌筛查效果。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To evaluate the participation rate and detection of colorectal neoplasms based on annual fecal immunochemical testing (FIT) for three consecutive years in a population-based colorectal cancer screening program in China. Methods: Based on a population-based colorectal cancer screening program conducted from May 2018 to May 2021 in 6 centers in China, 7 793 eligible participants aged 50-74 were included and offered free FIT and colonoscopy (for those who were FIT-positive on initial screening). At baseline, all participants were invited to receive FIT. In subsequent screening rounds, only FIT-positive participants who did not undergo colonoscopy or FIT-negative participants were invited to have repeated FIT screening. FIT-positive participants were recommended to undertake colonoscopy and pathological examination (if abnormalities were found during colonoscopy). An overall of three rounds of annual FIT screening were conducted. The primary outcomes of the study were the participation rate of FIT screening, the compliance rate of colonoscopy for FIT-positive participants, and the detection rate of colorectal neoplasms. Results: Among the 7 793 participants included in this study, 3 310 (42.5%) were male, with age of (60.50±6.49) years. The overall participation rates for the first, second and third round of FIT screening were 94.0%(7 327/7 793), 86.8% (6 048/6 968) and 91.3% (6 113/6 693), respectively. Overall, 7 742 out of 7 793 participants (99.3%) attended at least one round of screening, and 5 163 out of 7 793 participants (66.3%) attended all three rounds of screening. The positivity rate was significantly higher in the first (14.6%, 1 071/7 327) round compared with the second (5.6%, 3 41/6 048) and third (5.5%, 3 39/6 113) screening rounds (P<0.001). The overall compliance rates of colonoscopy examination among FIT-positive subjects were over 70% in three rounds, which were 76.3% (817/1 071), 75.7% (258/341) and 71.7% (243/339), respectively. In a multivariate logistic regression model considering factors including sex, education background, smoking, alcohol drinking, previous colonoscopy examination, colonic polyp history and family history of colorectal cancer among first-degree relatives, gender and smoking status were related factors affecting the participation rate of FIT screening, with higher rate in males and non-smokers. In addition, logistic regression analysis also found that age was negatively correlated with the compliance rate of colonoscopy in FIT positive patients. The detection rate of advanced tumors (colorectal cancer + advanced adenoma) declined from the first round to subsequent rounds [1st round: 1.15% (90/7 793); 2nd round: 0.57% (40/6 968); and 3rd round: 0.58% (39/6 693)], however, the positive predictive value for advanced neoplasms increased round by round, and was 11.02% in the first screening round, 15.50% in the second screening round, and 16.05 % in the third screening round. In each screening round, the detection rate for advanced neoplasms was higher in men than that in women, and increased with age. Conclusions: Annual repeated FIT screening has high acceptance and satisfying detection rates in the Chinese population. To optimize and improve the effectiveness of colorectal cancer screening, multi-round repeated FIT screening should be implemented while ensuring high participation rates. 目的: 评价连续3轮次年度粪便免疫化学试验(FIT)在中国人群结直肠癌筛查中的参与率和结直肠病变检出情况。 方法: 基于2018年5月至2021年5月在全国6个中心开展的一项人群结直肠癌筛查研究,共纳入了7 793例50~74岁符合研究条件的受试者,为其提供免费的FIT检测和结肠镜检查(仅针对FIT初筛阳性者)。在基线时,所有受试者均受邀接受FIT筛查。在后续轮次筛查中,仅邀请FIT阳性但未接受结肠镜检查者或FIT阴性者进行重复FIT筛查。FIT阳性者推荐接受结肠镜和病理检查(如结肠镜下有异常发现)。研究共计开展了3轮次每年1次的FIT筛查,主要研究结局为FIT参与率、FIT阳性者的结肠镜检查参与率以及结直肠肿瘤的检出率。 结果: 7 793例受试者中男3 310人(42.5%),年龄为(60.50±6.49)岁。第1轮、第2轮和第3轮FIT筛查的参与率分别为94.0%(7 327/7 793)、86.8%(6 048/6 968)和91.3%(6 113/6 693)。在7 793例参与者中,99.3%(7 742/7 793)参加了至少1轮筛查,66.3%(5 163/7 793)参加了全部3轮筛查。第1轮筛查人群的FIT阳性率(14.6%,1 071/7 327)高于第2轮(5.6%,341/6 048)和第3轮(5.5%,339/6 113)筛查(均P<0.001)。FIT阳性受试者结肠镜检查依从率在3轮筛查中均达到70%以上,分别为76.3%(817/1 071)、75.7%(258/341)和71.7%(243/339)。logistic多因素回归分析显示,性别和吸烟状态是影响FIT筛查参与率的影响因素,男性和不吸烟者的FIT筛查参与率较高。此外,年龄与FIT阳性者的结肠镜检查依从率呈负相关。经过3轮筛查,进展期肿瘤(结直肠癌+进展期腺瘤)的检出率逐轮下降[第1轮:1.15%(90/7 793);第2轮:0.57%(40/6 968);第3轮:0.58%(39/6 693)],但进展期肿瘤的阳性预测值逐轮增加,分别为11.02%、15.50%和16.05%。在各轮次筛查中,男性病变检出率均高于女性,且检出率均随着年龄增长而增加。 结论: 每年1次的重复FIT筛查在中国人群中具有较好的接受度以及较高的病变检出率。为了优化和提升人群结直肠癌筛查效果,应在保证人群筛查参与率的条件下推行多轮次重复FIT筛检。.

来源:Zhonghua Zhong Liu Za Zhi,查看原文。版权归原作者所有。

引用

  1. Li N, Zhou YY, Lu M, et al. [Participation rate and detection of colorectal neoplasms based on multi-round fecal immunochemical testing for colorectal cancer screening in the Chinese population]. Zhonghua Zhong Liu Za Zhi. 2023. PMID: 38110312. doi:10.3760/cma.j.cn112152-20230221-00073

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。